Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients

L. Lasagna, S. Peveri, E. Pilotti, M. Corradi, G. Bertorelli (Parma, Italy)

Source: Annual Congress 2008 - Inflammatory biomarkers
Session: Inflammatory biomarkers
Session type: Thematic Poster Session
Number: 1105
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Lasagna, S. Peveri, E. Pilotti, M. Corradi, G. Bertorelli (Parma, Italy). Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients. Eur Respir J 2008; 32: Suppl. 52, 1105

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cytokines in exhaled breath condensate of patients with asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 671s
Year: 2006

Inflammatory markers in exhaled breath condensate of two COPD phenotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005

Inflammatory mediators in exhaled breath condensate in young patients with bronchiectases
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008


8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Inflammatory markers in exhaled breath condensate in bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004

Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006

Inflammatory mediators in exhaled breath condensate, induced sputum and saliva
Source: Eur Respir J 2004; 24: Suppl. 48, 678s
Year: 2004

Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

pH in exhaled breath condensate of patients with inflammatory airway diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 240s
Year: 2003

Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 438s
Year: 2003

Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 61s
Year: 2005

Eotaxin in exhaled breath condensate of stable and unstable asthma patients
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010

Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


Increased lactate concentrations in exhaled breath condensate (EBC) in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 584s
Year: 2007